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Olfactory bulb (OB) plays an important role in protecting against harmful substances
via the secretion of antioxidant and detoxifying enzymes. Environmental enrichment (EE)
is a common rehabilitation method and known to have beneficial effects in the central
nervous system. However, the effects of EE in the OB still remain unclear. At 6 weeks of
age, CD-1® (ICR) mice were assigned to standard cages or EE cages. After 2 months,
we performed proteomic analysis. Forty-four up-regulated proteins were identified in EE
mice compared to the control mice. Gene Ontology analysis and Kyoto Encyclopedia of
Genes and Genomes Pathway demonstrated that the upregulated proteins were mainly
involved in metabolic pathways against xenobiotics. Among those upregulated proteins,
9 proteins, which participate in phase I or II of the xenobiotic metabolizing process and are
known to be responsible for ROS detoxification, were validated by qRT-PCR. To explore
the effect of ROS detoxification mediated by EE, glutathione activity was measured by
an ELISA assay. The ratio of reduced glutathione to oxidized glutathione was significantly
increased in EE mice. Based on a linear regression analysis, GSTM2 and UGT2A1
were found to be the most influential genes in ROS detoxification. For further analysis
of neuroprotection, the level of iNOS and the ratio of Bax to Bcl-2 were significantly
decreased in EE mice. While TUNEL+ cells were significantly decreased, Ki67+ cells
were significantly increased in EE mice, implicating that EE creates an optimal state for
xenobiotic metabolism and antioxidant activity. Taken together, our results suggested
that EE protects olfactory layers via the upregulation of glutathione-related antioxidant
and xenobiotic metabolizing enzymes, eventually lowering ROS-mediated inflammation
and apoptosis and increasing neurogenesis. This study may provide an opportunity for
a better understanding of the beneficial effects of EE in the OB.
Keywords: environmental enrichment, olfactory bulb, metabolizing enzymes, antioxidant, detoxification,
glutathione
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INTRODUCTION
The olfactory bulb (OB) is a region of brain that plays a critical
role in health and pathological behaviors such as the detection
of hazards in the environment, food selection, olfactory memory
formation, mating, and maintenance of mood (1–4). Tight
communication between the OB and other olfactory systems can
transfer xenobiotics to the brain by the active axonal transport
of olfactory neurons, bypassing the blood brain barrier (5). To
maintain cellular integrity and homeostasis of the brain from
environmental chemicals, it is necessary to have active xenobiotic
metabolism during the olfactory transport (6).
Xenobiotic metabolism is a metabolism pathway that
modifies the chemical structure of foreign, either exogenous
or endogenous, substances so that maintain homeostasis and
cellular integrity. Xenobiotic metabolism process includes three
steps; Phase I modifies xenobiotics via hydrolysis, oxidation, and
reduction and thereby produces the active metabolites. Phase II
further conjugates the phase I product with transferase enzymes
to yield hydrophilic products. Lastly, Phase III excretes the
final modified product out of the cells via various transporters
(6). Namely, metabolizing enzymes such as the cytochrome
P450 (CYPs) family, the UDP-glucuronosyltransferases (UGT)
family, glutathione-transferases (GST) family and the aldehyde
dehydrogenase (ADH) family are involved in the detoxification
process (6, 7). Especially, the phase II enzymes such as UGT and
GST family plays an important role in determining the rate of
xenobiotic metabolism and ROS detoxification (8).
Previous studies have shown olfactory bulbectomy in rodents
leads to cortical and hippocampal cell death (9, 10), suggesting
that the OB is related to other brain regions. Moreover, the OB
is a special nervous structure that changes its neural cells over
lifetime. Several studies have shown that newly generated cells
in the subventricular zone (SVZ) of adult mouse migrate into
the OB through the rostral migratory stream (RMS), forming
functional granule cells in the OB and constituting the network
of the OB to other brain regions (11, 12). Since the OB constantly
interacts with external environment and encounters harmful air-
borne chemicals, the above ongoing process is important for
proper OB function (13).
Environmental enrichment (EE) is a rehabilitation strategy
for rodents and the enhancement of the brain by surroundings
that include various objects such as running wheels, novel toys
and allow large social interactions to experience the effects
of a complex combination of physical, cognitive, and social
stimulation in the brain (14–16). In many studies, EE has
been implicated in improvement of the brain functions such
as neuroprotection and neurogenesis in an animal model of
aging (17–20), ischemic brain injury (14), and neurodegenerative
diseases (14, 21). These diseases and brain injuries, accompanied
with an increase in oxidative stress and olfactory impairment,
eventually lead to a clinically significant problem (22, 23).
However, this event can be reversed by exercise via the increased
expression of antioxidant enzymes (17, 24).
Previous studies have investigated the effect of EE, odor
enrichment, and xenobiotic inhalant on the OB of normal mice
(25–27). Allowing xenobiotic inhalants or various odorants in
a timely fashion, it could induce changes in gene expressions
and odor perception (25, 26). Several studies have reported the
beneficial effect of EE on the OB (25, 27). In contrast to the
previous studies, our study focuses on the effect of EE on the OB
of normal mice without utilizing any inhalant or timely-exposure
odorants.
The aim of this study was to determine whether there are
alterations in physiological responses after long-term exposure
to EE in the intact OB of normal mice. Here, we showed the
expression of metabolizing enzymes, which were predominated
in the OB of EE mice. Moreover, we found that EE enhances
neurogenesis and ROS detoxification, resulting in the reduction
of inflammation and apoptotic process. These results imply that
EE has beneficial effects on the OB through setting an optimal
status for antioxidant and xenobiotic metabolism.
MATERIALS AND METHODS
Experimental Procedures
Animals and Housing Conditions
At 6 weeks of age, a total of CD-1 R© (ICR) mice were assigned
randomly to either environmental enrichment (EE) or standard
cage (SC) group. For 2 months, EE mice were housed in a huge
cage (86 × 76 × 31 cm3) containing novel objects, such as
tunnels, shelters, toys, and running wheels for voluntary exercise,
and allowing for large social interaction (12–15 mice/cage)
(Figure 1A) while control mice were housed in standard cages
(27 × 22.5 × 14 cm3) without any novel objects (4–5 mice/cage)
(Figures 1B,C) (14). All animals were housed in a facility
accredited by the Association for Assessment and Accreditation
of Laboratory Animal Care (AAALAC) andwere given ad libitum
access to food and water under alternating 12-h light/dark cycles.
Used mice of this study were all female mice and purchased from
the Jackson Laboratory.
Ethic Statement
All procedures were reviewed and approved by the Animal
Care and Use Committee of the Yonsei University College of
Medicine (Identification code: 2014-0125-3). All procedures were
in accordance with the guidelines of the National Institutes of
Health’s Guide for the Care and Use of Laboratory Animals.
These regulations, notifications, and guidelines originated and
were modified from the Animal Protection Law (2008), the
Laboratory Animal Act (2008), and the Eighth Edition of the
Guide for the Care and Use of Laboratory Animals (NRC 2011).
They were sacrificed at 8 weeks after the housing conditions
under ketamine (100 mg/kg) and xylazine (10 mg/kg) anesthesia
by intraperitoneal injection. Thereafter, they were given an
intracardial perfusion of 4% paraformaldehyde, and the brain
tissues were harvested for histological assessments. All efforts
were made to minimize animal suffering.
Experimental Grouping
In this study, a total of 28 CD-1 R© (ICR) female mice at 6 weeks of
age were randomly housed either in environmental enrichment
(N = 14) or standard cages (N = 14). Among the subjects,
3 mice per group were recruited for the proteomics analysis
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FIGURE 1 | Experimental design for environmental enrichment. (A) Mice in an enriched environment accessed freely not only to water and food but also to tunnels,
shelters, toys, running wheels, and the large space of social interaction. (B,C) Mice in a standard cage freely accessed to water and food. (D) A schematic time
schedule for the experiment. Mice of 6 weeks of age were randomly assigned and reared in either a control cage or EE cage for 2 months. After the housing
conditions, brain tissues were harvested for proteomic analysis to see differentially expressed proteins. Long-term exposure to EE during adulthood is known to
induce the beneficial effects on brain health with cellular and molecular alterations.
after housing for 2 months (N = 6). To validate the results
of proteomics and measure iNOS levels, 4 mice per group were
further recruited at 8 weeks post-conditions (N = 8). Moreover,
3 mice per group were recruited for an ELISA assay to measure
glutathione activity and apoptosis process (N = 6). Finally, 4mice
per group were further recruited for histological assessments




Olfactory bulb of mouse brain tissues was homogenized in
200 µl of cold RIPA buffer (50mM Tris-HCl, pH 7.5, 1%
Triton X-100, 150mM NaCl, 0.1% sodium dodecyl sulfate
(SDS), 1% sodium deoxycholate) with a protease inhibitor
cocktail (Sigma-Aldrich, St. Louis, MO, USA) in the ice. The
tissue lysates were centrifugated for 20min at 13,000 g at
4◦C. The supernatant containing the protein extracts were
stored at −80◦C until use. The protein concentration of the
supernatant was determined using Bradford assay, according to
the manufacturer’s instructions.
In-solution Digestion
Protein samples were digested by in-solution method after
quantified using a bicinchoninic acid (BCA) assay kit (Thermo
Scientific, Foster City, CA, USA). Briefly, samples were resolved
in a digestion solution of 6M urea (Sigma-Aldrich) and 50mM
tris-HCl in water. Protein reduction was performed with 10mM
DTT (Sigma-Aldrich) for 1 h at 37◦C. Additionally, 55mM
iodoacetamide (Sigma-Aldrich) were treated for 30min at room
temperature in darkness for alkylation of cysteine residues. The
resulting samples were digested by sequencing-grade modified
trypsin (Promega, Madison, WI, USA) overnight at 37◦C.
The digested peptides were desalted using C18 Spin-Column
(Thermo Scientific).
TMT Labeling and OFF-GEL Fractionation
For TMT labeling, digested peptides were resuspended
in 200mM triethyl ammonium bicarbonate (TEAB,
Sigma-Aldrich). TMTTM Isobaric Mass Tagging reagent (Thermo
Scientific) were dissolved in anhydrous acetonitrile and added
to each sample. After incubation for 1 h at room temperature,
the reaction was quenched with 5% hydroxylamine. The labeled
samples were pooled into one tubes and separated with anAgilent
3100 OFF-GEL fractionator system (Agilent Technologies, Santa
Clara, CA, USA) according to manufacturer’s instructions.
Finally, resulting samples were desalted using C18 Spin-Column
(Thermo Scietific).
LC-MS Analysis and Data Acquisition
Prepared samples were analyzed using Q Exactive mass
spectrometer (Thermo Finnigan, San Jose, CA, USA) coupled
with EASY-nLC 1000 (Thermo Finnigan). The tryptic peptides
were loaded into a trap column (3µm sized C18 resin into 75µm
× 2 cm) and separated by the analytical column (3µm sized
C18 resin into 75µm × 50 cm) at a flow rate of 300 nL/min.
The separated peptides were eluted by solvent A (0.1% formic
acid in water) and solvent B (0.1% formic acid in acetonitrile)
with a linear gradient for 60min. Each MS scan was followed by
8 MS/MS scans of the most abundant peak to the eighth-most
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abundant peak of the MS scan in data-dependent method
with dynamic exclusion options (repeat duration was 30 s and
repeat count was set to 1). The normalized collision energy
for MS/MS was 27%. To identify peptides, TurboSEQUEST
(Thermo Electron, San Jose, CA, USA) was used to searchMS/MS
spectra against the Uniprot database for forward sequences
(17098 Mus musculus protein sequence entries as of July 15,
2014). The mass tolerance was set to 10 ppm for precursor ions,
0.8 Da for fragment ions. Carbamidomethylation of cysteine
(+57.0215 Da) and oxidation of methionine (+15.9949 Da)
were set as the static modifications and variable modifications,
respectively. Scaffold Q+S (version 4.3.4, Proteome Software
Inc., OR, USA) was used to compute probability of proteins and
peptides (28). Search results were validated using the protein
and peptide cut-off probabilities with>99% and 95% probability,
respectively. Spectral counts were calculated by Scaffold software
after normalization by total spectral counts of each MS run for
an estimate of expression fold change between the experimental
groups (29). An absorbance spectra peak for each interested
protein is provided in Figure S1.
Bioinformatics and Pathway Analysis
To identify protein function of the differentially expressed
genes, gene ontology (GO) was used for further analysis.
GO annotation analysis with the Database for Annotation,
Visualization and Integrated Discovery (DAVID) annotation tool
describes protein function with three basic categories: associated
biological process (BP), molecular function (MF) and cellular
components (CC). This categorization gives an overview of
the interested protein functions. Moreover, pathway enrichment
analysis was performed using the Kyoto Encyclopedia of Genes
and Genomes (KEGG) pathway. Pathways that are up-regulated
in EE mice compared to control mice were identified. Within
the identified pathways, genes that are involved in metabolism,
drug metabolism, and xenobiotic metabolism were sorted out for
further validation (Tables 1– 3).
Molecular Analysis
RNA Extraction
Total RNA was extracted from tissue samples as previously
described (30). Agilent 2100 Bioanalyzer (Agilent Technologies,
Palo Alto, CA, USA) with the A260/A280 ratio for quality control
analysis was used to evaluate purity of RNA extracted from
olfactory bulb tissues, and visual valuation of the 28S:18S rRNA
ratio using gel electrophoresis was used to evaluate the RNA
integrity.
Quantitative Real-Time PCR (qRT-PCR)
To further validate proteomic analysis, qRT-PCR for interested
differentially expressed genes was performed in triplicate.
One microgram of purified total RNA was used for reverse
transcription into cDNA using a ReverTra Ace R© qPCR TR
master Mix with gDNA remover (TOYOBO). The expression
of each gene of interest was profiled using a LightCycler 480
(Roche Applied Science, Mannheim, Germany) using the
LightCycler 480 SYBR Green master mix (Roche Applied
Science). The validated genes are as follows: subfamily A7
(ALDH1A7); Carboxylesterase 1D (CES1D); Cytochrome
P450, family 2, subfamily a, polypeptide 5 (CYP2A5); Serum
paraoxonase 1 (PON1); Cytochrome P450, family 1, subfamily a,
polypeptide 2 (CYP1A2); Dihydropyrimidinase (DPYS); Alcohol
dehydrogenase 1 (ADH1); Alcohol dehydrogenase [NADP(+)]
(AKR1A1); Crystalline, lambda1 (CRYL1), forward 5′-3′ and
reverse 5′-3′; UDP-glucuronosyltransferase 2 family, polypeptide
A1 (UGT2A1); Glutathione S-transferase, alpha3 (GSTA3);
Glutathione S-transferase Mu 2 (GSTM2); Epoxide hydrolase
1 (EPHX1); Thiosulfate sulfurtransferase (TST). To confirm
detoxifying activity by EE, we also identified iNOS level. And
glyceraldehyde-3-phosphate dehydrogenase (GADPH) was used
as the loading control. The expression level of each gene of
interest was obtained using the 2−∆∆Ct method (31). Target-gene
expression was normalized relative to the expression of GAPDH
and represented as fold change relative to the control. The primer
sequences are described in Table S1.
Glutathione Activity Assay (ELISA)
The concentration of total glutathione, oxidized glutathione,
ratio of reduced glutathione to oxidized glutathione were
measured in OB extracts using the glutathione detection kit from
Enzo Life Sciences (Enzo Life Sciences, East Farmingdale, NY,
USA, ADI-900-160) following the manufacturer’s instructions.
The values were obtained at 1:40 dilution and expressed
as pmol/well and each well contained the total volume
of 200 µl.
Western Blot
To measure the expression of apoptotic neuronal cells, the
protein was extracted as described above. The equal amounts
of protein samples (40 µg) were denatured and separated by
4–12% Bis-Tris gels in 1× NuPage MES SDS Running Buffer
(Invitrogen, Eugene, OR, USA). Proteins were transferred at
4◦C onto a polyvinylidene difluoride membrane (Invitrogen)
in NuPage Transfer Buffer (Invitrogen) with 20% (vol/vol)
methanol. Membranes were blocked and then incubated
overnight at 4◦C with the following antibodies: Anti-Bax (1:
1,000 dilution, Santa Cruz Biotechnology), Anti-Bcl-2 (1:1,000
dilution, Santa Cruz Biotechnology), and Anti-Actin (1:1,000
dilution, Santa Cruz Biotechnology). The next day, blots were
washed three times with TBS plus Tween 20 and incubated
at room temperature for 1 hr with horseradish peroxidase-
conjugated secondary antibodies (1:3,000 dilution, Santa Cruz).
An enhanced chemiluminescence detection system (Amersham
Pharmacia Biotech, Little Chalfont, UK) was used to visualize the




Immunohistochemistry was performed as previously
described (32). The animals were sacrificed and perfused
with 4% paraformaldehyde. The harvested brain tissues were
cryosectioned at 16-µm thickness along the sagittal plane,
and immunohistochemistry staining was performed on four
sections over a range of >128µm. Sections were stained with
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primary antibodies against Ki67 (1:200; Abcam), and secondary
antibodies such as Alexa Fluor 488 goat anti-Rabbit (1:400;
Invitrogen) and mounted on glass slides with fluorescent
mounting medium containing 4′,6-diamidino-2-phenylindole
(Vectorshield, Vector, Burlingame, CA). The stained sections
were analyzed using confocal microscopy (LSM700; Zeiss,
Gottingen, Germany). Ki67+ cell area (µm2) with respect to
DAPI area (/µm2) was evaluated using ZEN Imaging Software
(Blue edition; Zeiss).
Terminal Deoxynucleotidyl Transferase dUTP Nick
End Labeling (TUNEL) Assay
For analysis of apoptosis, the selected areas of the RMS
were analyzed for each group. Fluorometric TUNEL assay
(Promega, Madison, WI, USA) was conducted according to the
manufacturer’s protocol. Images of apoptotic cells were taken
using a fluorescent microscopy (LSM700), and positive apoptotic
cells (µm2) with respect to DAPI area (/µm2) were quantified
using ZEN Imaging Software (Blue edition; Zeiss).
Statistical Analysis
Statistical analyses were performed using Statistical Package for
Social Sciences (SPSS) software (IBM Corporation, Armonk,
NY, USA; version 23.0). All data were expressed as median
and interquartile range (25th−75th percentiles). Mann–Whitney
U-tests were used to compare the difference between groups.
Linear regression analysis was conducted to identify the
relationship between xenobiotic metabolizing proteins and ROS
detoxification (glutathione activity) and a univariate analysis
was also used identify relationships between EE and xenobiotic




Increased the Proteins Associated With
Metabolic Pathways and Xenobiotic
Metabolism
After placing mice in either SC cage or EE cage for 2 months, the
mice were sacrificed according to the time schedule (Figure 1D).
The proteomic analysis revealed that 44 up-regulated proteins
were identified in EE mice compared with control mice with a
cut-off fold change >1.5 (p < 0.05) (Table 1). The up-regulated
proteins in the OB of mice exposed to EE were categorized
based on biological processes (BP), molecular functions
(MF), and cellular components (CC) (Table 2). BP based GO
analysis identified the up-regulated proteins were related to
“oxidation-reduction process” (GO:0055114), “response to
toxic substance” (GO:0009636), “epoxygenase P450 pathway”
(GO:0019373), “metabolic process” (GO:0008152), “short-
chain fatty acid catabolic process” (GO:0019626), “aromatic
compound catabolic process” (GO:0019439), “ethanol catabolic
process” (GO:0006068), “cellular aromatic compound metabolic
process” (GO:0006725), “cellular response to cadmium ion”
(GO:0071276), “retinoic acid metabolic process” (GO:0042573),
and “drug metabolic process” (GO:0017144). Moreover, in Kyoto
Encyclopedia of Genes and Genomes (KEGG) pathway, the most
highlighted cluster in the up-regulated genes contains overall
themes for metabolic pathways and xenobiotic metabolism
(Table 3).
Differentially Expressed Proteins (DEPs)
Were Validated by qRT-PCR
After 8 weeks of the exposure to EE or SC, mice were sacrificed,
and the olfactory bulbs were extracted and lysed for proteomic
and qPCR analysis. The expression level of 44 identified proteins
were significantly different in terms of the expression level
between control group and EE group. The up-regulated proteins
via pathway analysis were validated using qRT-PCR analysis.
Xenobiotic metabolizing phase I enzymes, such as ALDH1A7,
DPYS, PON1, CRYL1, AKR1A1, CYP1A2, and xenobiotic
metabolizing phase II enzymes, such as UGT2A1, GSTM2,
GSTA3 were significantly increased in EE mice compared with
control mice (Figure 2; p< 0.05).
EE Enhanced Glutathione Activity and
Induced ROS Detoxification
Glutathione activity is important for the removal of ROS,
which generated from endogenous environment and during
xenobiotic metabolism, and glutathione redox status can be a
marker for oxidative stress. The number of oxidized glutathione
was significantly lower in EE mice compared to control mice
(Figure 3A; p < 0.05), and the ratio of reduced glutathione
(GSH) to oxidized glutathione (GSSG) was significantly higher
in EE mice compared to control mice (Figure 3B; p < 0.05),
and no significant difference in the number of total glutathione
was observed in between EE mice and control mice (Data not
shown).
The Significant Association Between
Xenobiotic Metabolizing Enzymes and
Glutathione Activity via EE Was Founded
Linear regression analysis was conducted to identify which
xenobiotic metabolizing enzymes mostly contribute to
glutathione activity (Table 4). In the analysis of oxidized
glutathione, GSTM2 (p = 0.008), GSTA3 (p = 0.022), CYP2A5
(p = 0.004), ALDH1A7 (p = 0.009), and UGT2A1 (p = 0.002)
were found to be significantly correlated. In the analysis of
GSH/GSSG, GSTM2 (p = 0.003), GSTA3 (p = 0.008), CYP2A5
(p = 0.029), ALDH1A7 (p = 0.004), UGT2A1 (p = 0.003),
CRYL1 (p= 0.049), AKR1A1 (p= 0.024), and DPYS (p= 0.016)
were found to be significantly correlated. The final stepwise
multiple regression model revealed a significant association
between oxidized glutathione and UGT2A1 (p = 0.002), and
significant associations between GSH/GSSG and GSTM2
(p = 0.024) and GSH/GSSG and UGT2A1 (p = 0.029). EE
was significantly associated with GSTM2 (Coefficient (SE)
= 0.625 (0.072); reference = SC; p < 0.001 and UGT2A1
(Coefficient (SE) = 2.688 (0.685); p < 0.001), individually.
Also, EE was significantly correlated with glutathione activity-
related factors including oxidized glutathione [Coefficient
(SE) = −1.186 (0.319); p = 0.002] and the ratio of GSH
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TABLE 1 | List of proteins found to be up-regulated proteins in OB of mice treated with EE.
Accession number Accession name Protein name Gene symbol Fold change P-value
Q80ZU7 BPIB3_MOUSE BPI fold-containing family B member 3 Bpifb3 4.4 0.0001
P08074 CBR2_MOUSE Carbonyl reductase [NADPH] 2 Cbr2 3.9 0.0001
Q5SQ27 Q5SQ27_MOUSE MCG140354 Sec14l3 3.1 0.0001
Q8VCT4 CES1D_MOUSE Carboxylesterase 1D Ces1d 3.1 0.0001
P11679 K2C8_MOUSE Keratin, type II cytoskeletal 8 Krt8 3.1 0.0001
P97872 FMO5_MOUSE Dimethylaniline monooxygenase [N-oxide-forming] 5 Fmo5 2.9 0.0001
P33267 CP2F2_MOUSE Cytochrome P450 2F2 Cyp2f2 2.9 0.0001
Q80X89 UD2A1_MOUSE UDP-glucuronosyltransferase 2A1 Ugt2a1 2.8 0.0001
Q91X75 Q91X75_MOUSE Cyp2a4 protein Cyp2a5 2.7 0.0001
P05784 K1C18_MOUSE Keratin, type I cytoskeletal 18 Krt18 2.7 0.0001
Q8K157 GALM_MOUSE Aldose 1-epimerase Galm 2.6 0.0001
Q8K1G6 Q8K1G6_MOUSE Protein Muc5b Muc5b 2.6 0.0001
P52430 PON1_MOUSE Serum paraoxonase/arylesterase 1 Pon1 2.5 0.0001
Q8C6B0 Q8C6B0_MOUSE MCG20149, isoform CRA_a Mettl7a1 2.5 0.0001
Q8BHB9 CLIC6_MOUSE Chloride intracellular channel protein 6 Clic6 2.5 0.0008
P40936 INMT_MOUSE Indolethylamine N-methyltransferase Inmt 2.3 0.0001
P15626 GSTM2_MOUSE Glutathione S-transferase Mu 2 Gstm2 2.3 0.0001
P00329 ADH1_MOUSE Alcohol dehydrogenase 1 Adh1 2.3 0.0001
P00186 CP1A2_MOUSE Cytochrome P450 1A2 Cyp1a2 2.3 0.0001
Q9WV19 Q9WV19_MOUSE Cytochrome P450, family 2, subfamily g, polypeptide 1 Cyp2g1 2.2 0.0001
A2BGH0 BPIB4_MOUSE BPI fold-containing family B member 4 Bpifb4 2.1 0.0001
Q91WU0 CES1F_MOUSE Carboxylesterase 1F Ces1f 2.1 0.0001
O88312 AGR2_MOUSE Anterior gradient protein 2 homolog Agr2 2.1 0.0001
E9QN99 E9QN99_MOUSE Alpha/beta hydrolase domain-containing protein 14B Abhd14b 2.1 0.0001
P12265 BGLR_MOUSE Beta-glucuronidase Gusb 2.1 0.0001
Q9EQF5 DPYS_MOUSE Dihydropyrimidinase Dpys 2.1 0.0023
P30115 GSTA3_MOUSE Glutathione S-transferase A3 Gsta3 2.1 0.0001
Q9D379 HYEP_MOUSE Epoxide hydrolase 1 Ephx1 2.0 0.0001
Q9R092 H17B6_MOUSE 17-beta-hydroxysteroid dehydrogenase type 6 Hsd17b6 2.0 0.0015
Q9D8W7 OCAD2_MOUSE OCIA domain-containing protein 2 Ociad2 1.9 0.0001
J3QMN6 J3QMN6_MOUSE Dimethylaniline monooxygenase [N-oxide-forming] Fmo6 1.9 0.0001
P56395 CYB5_MOUSE Cytochrome b5 Cyb5a 1.9 0.0001
Q99KP3 CRYL1_MOUSE Lambda-crystallin homolog Cryl1 1.8 0.0001
Q5SGK3 AOXB_MOUSE Aldehyde oxidase 3 Aox3l1 1.8 0.0001
O70475 UGDH_MOUSE UDP-glucose 6-dehydrogenase Ugdh 1.7 0.0001
Q7TNG8 LDHD_MOUSE Probable D-lactate dehydrogenase, mitochondrial Ldhd 1.7 0.0001
B2RX12 MRP3_MOUSE Isoform 2 of Canalicular multispecific organic anion transporter 2 Abcc3 1.7 0.0011
O35945 AL1A7_MOUSE Aldehyde dehydrogenase, cytosolic 1 Aldh1a7 1.7 0.0001
Q5SXG7 VMO1_MOUSE Vitelline membrane outer layer protein 1 homolog Vmo1 1.6 0.0022
Q91WR8 GPX6_MOUSE Glutathione peroxidase 6 Gpx6 1.6 0.0001
Q9JII6 AK1A1_MOUSE Alcohol dehydrogenase [NADP(+)] Akr1a1 1.6 0.0001
P52196 THTR_MOUSE Thiosulfate sulfurtransferase Tst 1.6 0.0001
P59242 CING_MOUSE Cingulin Cgn 1.6 0.0014
P37040 NCPR_MOUSE NADPH–cytochrome P450 reductase Por 1.5 0.0001
to GSSG [Coefficient (SE) = 26.218 (5.403); p < 0.001],
respectively.
EE Mediated Neuroprotection and
Preserved Newly Generated Cells
The expression of iNOS is highly up-regulated when the
cells are in oxidative stress, and the relationship between
apoptotic markers (Bax and Bcl-2) is important for regulating
cell apoptosis. To measure the expression of iNOS, RT-PCR
was performed with the referenced primers (Table S1) (33).
The representative figures of RT-PCR for the iNOS expression
between EE and control group were shown in Figure 4A. The
expression of iNOS in EE mice was significantly lower than
that of control mice (Figure 4B; p < 0.05). To further evaluate
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TABLE 2 | Gene ontology with Database for Annotation, Visualization, and Integrated Discovery (DAVID) generated by EE up-regulated genes.
Category ID Term Count % P-value Genes
GOTERM_BP_DIRECT GO:0055114 Oxidation-reduction process 15 34.88 <0.0001 CYP2F2, LDHD, UGDH, CYB5A,
CYP1A, POR, FMO5, CRYL1, FMO6,
CBR2, AKR1A1, GPX6, ADH1,
HSD17B6, ALDH1A7
GOTERM_BP_DIRECT GO:0009636 Response to toxic substance 5 11.63 <0.0001 CYP2F2, PON1, EPHX1, CES1D,
INMT
GOTERM_BP_DIRECT GO:0019373 Epoxygenase P450 pathway 3 6.98 0.0019 CYP2G1, CYP2F2, CYP2A5
GOTERM_BP_DIRECT GO:0008152 Metabolic process 6 13.95 0.0030 GSTM2, GSTA3, GUSB, UGDH,
UGT2A1, ALDH1A7
GOTERM_BP_DIRECT GO:0019626 Short-chain fatty acid catabolic process 2 4.65 0.0043 CES1F, CES1D
GOTERM_BP_DIRECT GO:0019439 Aromatic compound catabolic process 2 4.65 0.0129 PON1, EPHX1
GOTERM_BP_DIRECT GO:0006068 Ethanol catabolic process 2 4.65 0.0150 ADH1, ALDH1A7
GOTERM_BP_DIRECT GO:0006725 Cellular aromatic compound metabolic process 2 4.65 0.0150 EPHX1, CYP1A2
GOTERM_BP_DIRECT GO:0071276 Cellular response to cadmium ion 2 4.65 0.0256 CYP2A5, CYP1A2
GOTERM_BP_DIRECT GO:0042573 Retinoic acid metabolic process 2 4.65 0.0319 ADH1, ALDH1A7
GOTERM_BP_DIRECT GO:0017144 Drug metabolic process 2 4.65 0.0381 FMO5, CYP1A2
GOTERM_MF_DIRECT GO:0016491 Oxidoreductase activity 13 30.23 <0.0001 FMO5, CRYL1, CBR2, GPX6,
CYP2F2, AKR1A1, ADH1, LDHD,
UGDH, HSD17B6, ALDH1A7,
CYP1A2, POR
GOTERM_MF_DIRECT GO:0016712 Oxidoreductase activity, acting on paired
donors, with incorporation or reduction of
molecular oxygen, reduced flavin or flavoprotein
as one donor, and incorporation of one atom of
oxygen
4 9.30 0.0001 CYP2G1, CYP2F2, CYP2A5, CYP1A2
GOTERM_MF_DIRECT GO:0050660 Flavin adenine dinucleotide binding 4 9.30 0.0006 FMO5, FMO6, LDHD, POR
GOTERM_MF_DIRECT GO:0020037 Heme binding 5 11.63 0.0006 CYP2G1, CYP2F2, CYP2A5, CYB5A,
CYP1A2
GOTERM_MF_DIRECT GO:0019899 Enzyme binding 6 13.95 0.0016 GSTM2, CYP2A5, EPHX1, CYB5A,
CYP1A2, POR
GOTERM_MF_DIRECT GO:0004497 Monooxygenase activity 4 9.30 0.0018 FMO5, FMO6, CYP2F2, CYP1A2
GOTERM_MF_DIRECT GO:0050661 NADP binding 3 6.98 0.0034 FMO5, FMO6, POR
GOTERM_MF_DIRECT GO:0008392 Arachidonic acid epoxygenase activity 3 6.98 0.0049 CYP2G1, CYP2F2, CYP2A5
GOTERM_MF_DIRECT GO:0008395 Steroid hydroxylase activity 3 6.98 0.0065 CYP2G1, CYP2F2, CYP2A5
GOTERM_MF_DIRECT GO:0042803 Protein homodimerization activity 7 16.28 0.0081 GSTM2, CRYL1, GALM, ADH1,
CLIC6, PON1, AGR2
GOTERM_MF_DIRECT GO:0005506 Iron ion binding 4 9.30 0.0117 CYP2G1, CYP2F2, CYP2A5, CYP1A2
GOTERM_MF_DIRECT GO:0004499 N,N-dimethylaniline monooxygenase activity 2 4.65 0.0199 FMO5, FMO6
GOTERM_MF_DIRECT GO:0016705 Oxidoreductase activity, acting on paired
donors, with incorporation or reduction of
molecular oxygen
3 6.98 0.0206 CYP2F2, CYP2A5, CYP1A2
GOTERM_MF_DIRECT GO:0004745 Retinol dehydrogenase activity 2 4.65 0.0459 ADH1, HSD17B6
GOTERM_CC_DIRECT GO:0031090 Organelle membrane 7 16.28 <0.0001 FMO5, FMO6, CYP2F2, CYP2A5,
EPHX1, CYB5A, CYP1A2
GOTERM_CC_DIRECT GO:0070062 Extracellular exosome 18 41.86 <0.0001 GSTA3, GUSB, UGDH, DPYS,
ABHD14B, CYB5A, SEC14L3, TST,
CRYL1, GALM, KRT18, AKR1A1,
KRT8, CLIC6, PON1, METTL7A1,
VMO1, MUC5B
GOTERM_CC_DIRECT GO:0043231 Intracellular membrane-bounded organelle 10 23.26 <0.0001 FMO5, CYP2F2, GUSB, PON1,
HSD17B6, EPHX1, CYB5A, CYP1A2,
POR, MUC5B
GOTERM_CC_DIRECT GO:0005783 Endoplasmic reticulum 11 25.58 0.0004 FMO5, CYP2F2, GUSB, CES1F,
HSD17B6, EPHX1, CYB5A, CES1D,
CYP1A2, AGR2, POR
GOTERM_CC_DIRECT GO:0005789 Endoplasmic reticulum membrane 8 18.60 0.0007 FMO5, FMO6, CYP2F2, CYP2A5,
EPHX1, CYB5A, CYP1A2, POR
GOTERM_CC_DIRECT GO:0005829 Cytosol 10 23.26 0.0116 GSTM2, CRYL1, AKR1A1, ADH1,
UGDH, CES1F, DPYS, CES1D,
ABHD14B, INMT
GOTERM_CC_DIRECT GO:0005615 Extracellular space 8 18.60 0.0385 TST, AKR1A1, GUSB, CES1F, PON1,
CES1D, AGR2, MUC5B
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TABLE 3 | Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways identified to be significantly up-regulated from EE using Database for Annotation, Visualization,
and Integrated Discovery (DAVID) software.
Category Term Count % P-value Genes
KEGG_PATHWAY Metabolic pathways 16 37.20930233 <0.0001 GUSB, UGDH, DPYS, CYP1A2, TST, CRYL1,
GALM, CBR2, AKR1A1, ADH1, CYP2A5, PON1,
HSD17B6, UGT2A1, CES1D, ALDH1A7
KEGG_PATHWAY Metabolism of xenobiotics by
cytochrome P450
8 18.60465116 <0.0001 GSTM2, GSTA3, CBR2, CYP2F2, ADH1, EPHX1,
UGT2A1, CYP1A2
KEGG_PATHWAY Drug metabolism—cytochrome P450 7 16.27906977 <0.0001 GSTM2, FMO5, GSTA3, FMO6, ADH1, UGT2A1,
CYP1A2
KEGG_PATHWAY Pentose and glucuronate
interconversions
5 11.62790698 <0.0001 CRYL1, AKR1A1, GUSB, UGDH, UGT2A1
KEGG_PATHWAY Retinol metabolism 6 13.95348837 <0.0001 ADH1, CYP2A5, HSD17B6, UGT2A1, ALDH1A7,
CYP1A2
KEGG_PATHWAY Drug metabolism—other enzymes 4 9.302325581 0.0007 GUSB, DPYS, UGT2A1, CES1D
KEGG_PATHWAY Glutathione metabolism 3 6.976744186 0.0156 GSTM2, GSTA3, GPX6
KEGG_PATHWAY Glycolysis / Gluconeogenesis 3 6.976744186 0.0220 GALM, AKR1A1, ADH1
KEGG_PATHWAY Steroid hormone biosynthesis 3 6.976744186 0.0367 HSD17B6, UGT2A1, CYP1A2
KEGG_PATHWAY Ascorbate and aldarate metabolism 2 4.651162791 0.0904 UGDH, UGT2A1
FIGURE 2 | Validation of the up-regulated proteins associated with xenobiotic metabolism. Among the 44 up-regulated proteins, which were associated with
xenobiotic metabolism and detoxifying enzymes, a total of 9 genes, phase I (ALDH1A7, DPYS, PON1, CRYL1, AKR1A1, CYP1A2) (A) and phase II (UGT2A1,
GSTIM2, GSTA3) (B), were significantly increased in EE mice compared to control mice (*p < 0.05, by Mann-Whitney U test). Values are median (interquartile range)
and a red tick line indicates the relative expression of control mice.
FIGURE 3 | Glutathione activity. The number of oxidized glutathione in EE mice was significantly decreased compared to control mice (A), and GSH/GSSG ratio was
significantly increased in EE mice compared with control mice (B). Values are median (interquartile range). An asterisk indicates significant difference (*p < 0.05, by
Mann–Whitney U-test).
Frontiers in Neurology | www.frontiersin.org 8 July 2018 | Volume 9 | Article 425
Seo et al. Environmental Enrichment and Xenobiotic Metabolism
TABLE 4 | Linear regression analysis of xenobiotic metabolism-related genes for predicting glutathione activity.
Factor Oxidized Glutathione GSH/GSSG
Model Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
Genes Coefficient (SE) p-value Coefficient (SE) p-value Coefficient (SE) p-value Coefficient (SE) p-value
GSTM2 −1.526 (0.505) 0.008* – – 32.762 (9.241) 0.003* 22.895 0.024*
GSTA3 −0.881 (0.346) 0.022* – – 19.249 (6.399) 0.008* – –
CYP2A5 −0.587 (0.176) 0.004* – – 9.231 (3.837) 0.029* – –
ALDH1A7 −0.432 (0.145) 0.009* – – 8.993 (2.719) 0.004* – –
UGT2A1 −0.307 (0.083) 0.002* −0.307 0.002* 5.768 (1.678) 0.003* 3.916 0.029*
CRYL1 −1.863 (1.052) 0.096 NA 42.259 (19.818) 0.049* – –
AKR1A1 −1.333 (0.699) 0.075 32.038 (12.823) 0.024* – –
DPYS −0.517 (0.267) 0.071 12.925 (4.817) 0.016* – –
PON1 −0.111 (0.214) 0.611 5.318 (3.994) 0.202 NA
*p < 0.05; SE, standard error; NA, not associated. Linear regression analysis was conducted to identify significantly xenobiotic metabolism-related genes affecting oxidized glutathione
(OG) and the ratio of reduced glutathione (GSH) to oxidized glutathione (GSSG) in olfactory bulb of mouse brain. The stepwise multiple linear regressions included UGT2A1 and GSTM2
in the final models.
FIGURE 4 | iNOS expression and apoptotic process. The expression of iNOS in the OB of EE mice were significantly decreased compared to control mice (A,B).
Moreover, the ratio of Bax to Bcl-2 in EE mice was significantly decreased compared to control mice (C,D). Values are median (interquartile range). An asterisk
indicates significant difference (*p < 0.05, by Mann–Whitney U-test).
the apoptotic process and neuroprotection in the OB, western
blot was conducted. The representative figures of WB for Bax,
Bcl-2, and Actin between EE and control group were shown
in Figure 4C. The ratio of Bax, a pro-apoptosis marker to
Bcl-2, an anti-apoptosis marker was significantly decreased in
EE mice compared to control mice (Figure 4D; p < 0.05).
Taken together, the upregulation of xenobiotic metabolizing
enzymes mediated by EE induces glutathione-mediated ROS
detoxification, eventually reducing oxidative stress and apoptosis
process. IHC was performed to evaluate neuroprotection and
cell proliferation in the RMS. The RMS is a structure that
have a full of neuroblasts, which originated from the SVZ.
These neuroblasts further migrate along the RMS into the
OB, resulting in the replacement of OB interneurons. In the
analysis of TUNEL assay, apoptotic cells were significantly
decreased in the RMS of EE mice compared to control mice
(Figures 5A–G; p < 0.05) In the analysis of newly generated
cells, Ki67+ cells in the RMS were significantly increased
in EE mice compared with control mice (Figures 5H–N;
p< 0.05).
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FIGURE 5 | Histological assessments for neuroprotection and cell proliferation in the RMS. TUNEL+ cells were indicated in green (A–F). TUNEL+ cells in EE mice
were significantly decreased in the RMS compared to control mice (G; p < 0.05). Ki67+ cells were indicated in green (H–M). Ki67+ cells in EE mice were significantly
increased in the RMS compared to control mice (N; p < 0.05). Values are median (interquartile range). An asterisk indicates significant difference (*p < 0.05, by
Mann–Whitney U-test). Scale bars for (A,C,H,L) represent 100µm, scale bars for (B,D,I,M) represent 20µm, and scale bars for (E,F,J,K) represent 10µm.
DISCUSSION
In this study, we provided evidences that EE has the protective
effects on the OB through setting an optimal status for
antioxidant and xenobiotic metabolism. The proteomic analysis
revealed the DEPs in the OB of EE mice compared with control
mice. GO analysis was conducted to identify protein function
with DAVID 6.8 beta annotation tool and KEGG pathways. In
the KEGG pathways, the most highlighted themes were general
metabolism and xenobiotic metabolism within several biological
processes.
To validate the expression of the up-regulated proteins, qRT-
PCR was performed. Among the phase I metabolizing enzymes,
ALDH1A7, DPYS, PON1, CRYL1, AKR1A1, CYP1A2 were
found to be significantly increased in EE mice compared with
control mice and among the phase II metabolizing enzymes,
UGT2A1, GSTM2, GSTA3 were found to be significantly
increased in EEmice compared with control mice. The activation
ratio of phase I and phase II xenobiotic metabolism is important
because the product of phase I could be more deleterious than
the original form of xenobiotics. The phase-II genes encode
for a battery of enzymes that are essential in the antioxidation
and detoxification of xenobiotics and endogenous reactive
electrophilic compounds (34). The transcriptional regulation of
the phase II genes is achieved by the binding of nuclear factor
erythroid2- related factor (Nrf2) to the consensus antioxidant
response element (ARE) sequence in the promoter regions.
Nrf2 has been shown to regulate the expression of a group
of genes encoding cytoprotective enzymes in response to cell
exposure to certain toxicants, including reactive oxygen
species (ROS), electrophiles, as well as dithiolethiones,
isothiocyanates, and triterpenoids (35). The target genes
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include ones encoding such enzymes as antioxidative, catalyzing
electrophile conjugation, glutathione homeostasis, producing
reducing equivalents, proteasome function and other. Among
others, glutathione reductase catalyzes the reduction of
glutathione disulfide (GSSG) to the sulfhydryl form glutathione
(GSH), which is a critical molecule in resisting oxidative stress
and maintaining the reducing environment of the cell (36).
To further analyze the rate of phase II enzyme activity, one of
the phase II enzymes, glutathione, the GSH/GSSG detection assay
was performed. The GSH/GSSG ratio in the OB of EE mice was
significantly higher than in the OB of control mice, and oxidized
glutathione was significantly decreased in EE mice compared to
control mice. However, the level of total glutathione was not
significantly different between the groups. These results suggest
that EE has beneficial effects on the OB of the mouse brain by
setting an optimal status for getting rid of ROS via enhancement
of antioxidant and detoxifying enzyme activity.
To further investigate the relationship between glutathione-
mediated ROS detoxification and the validated up-regulated
metabolizing enzymes, the regression analyses were conducted
to identify whether the genes predict the glutathione activity.
While GSTM2, GSTA3, CYP2A5, ALDH1A7, UGT2A1 were
correlated in oxidized glutathione, GSTM2, GSTA3, CYP2A5,
ALDH1A7, UGT2A1, CRYL1, AKR1A1, DPYS were correlated
in GSH/GSSG ratio. The stepwise multiple linear regression
indicated that UGT2A1 was the most influential gene in oxidized
glutathione, and GSTM2 and UGT2A1 were the most influential
genes in the GSH/GSSG ratio.
GSTM2 stabilizes reactive metabolites formed by CYPs, UGT,
and ST, and the proper activity of GST isoenzymes is important
for olfactory acuity (37). A fluctuation in the GST activity was
observed in striatal neurons of Huntington’s diseases, reflecting
its protective role for oxidative damage to DNA, proteins, and
lipids (38). The expression of GST activity is highly expressed
in rat olfactory bulb compared to that of the cerebral cortex
(37). Interestingly, the transcriptional level of Nrf2 is positively
correlated to GST activities in most cases (39). GSTM2 also takes
an important role in glutathione-mediated antioxidant activity
and clearance of odorants (40).
UGTs, consisting of genetically variable family of enzymes,
detoxify various exogenous xenobiotics from air pollutants to
food and endogenous lipids (41). These enzymes involved in all
three phases of xenobiotic metabolism (42) and are detectable
in olfactive mucosa and olfactory bulb (43). Various isoforms of
UGTs are highly expressed in the olfactory area. Their expression
is highly related to the transfer rate of xenobiotics via the nasal
pathway to the brain, the modulation of olfactory perception,
and the detoxification of exogenous or endogenous compounds,
which are important for physiological olfactory processing in the
system (44).
During xenobiotic metabolism, the numerous amounts of
ROS and reactive nitrogen species generate in the membrane
of the cell and mitochondria. These reactive species can exert
deleterious effects on DNA, protein, and membrane of the cell
(44). Furthermore, excessive ROS generation or oxidative stress
activates stress-mediatedMAPKs, ultimately leading to cell death
(37). The accumulation of endogenous ROS can be alleviated
by either enzymatic or non-enzymatic antioxidants defense (45).
In RT-PCR and WB analysis, the significant reductions of the
iNOS expression and apoptotic process were observed in EEmice
compared with control mice. This neuroprotective effect may be
due to the up-regulation of glutathione activity and the reduction
of ROS.
The OB relays various information from the olfactory
epithelium, which has a direct contact with external
environment, to the olfactory cortex (43, 46).When encountering
and metabolizing xenobiotics, continuous neural regeneration
and synaptic plasticity occur in sensory cell axons and mitral
cells of the OB (6). Most of the progenitor cells from the
subventricular zone that migrate along the migratory stream to
the OB differentiate into granule cells (GC) (47). These cells are
inhibitory interneurons, and their activity is extremely important
to modulate mitral cell activity and to accurately shape the
output from the OB to higher olfactory centers (38, 40). Notably,
olfactory interneurons are continuously generated throughout
adulthood and their integration in the OB circuits is regulated
by sensory experience (48). Several studies have shown that
exposing animals to an olfactory enrichment increases survival
of adult-born neurons in the OB (49, 50). In the presence
of powerful neurogenic stimulus, such as voluntary exercise,
the proliferative capability of SVZ stem cells turns out to be
more plastic (51). Moreover, EE increases neurogenesis in the
granular cell layer (GCL) of the adult OB (52). Consistent with
the previous studies, our results showed that EE significantly
reduced the apoptosis of newly regenerated cells in the RMS.
Oxidative stress in brain is related with many factors such
as environmental toxin, aging, and diseases. Previous studies
have shown oxidative stress could be alleviated by environmental
enrichment (17, 24, 53), and the dramatic effect can be shown in
the aging rat brain (17, 24). EE also mediates various functional
improvements via the increased expression of growth factors
such as FGF-2 in the hypoxic ischemic mice (14). Moreover, EE
also induces behavioral and functional improvement associated
with synaptic plasticity and neurogenesis (54–57). However,
the mechanisms underlying the effect of EE on xenobiotic
metabolism in the OB are less clear. As indicated in the study
of Yokota et al., EE during the perinatal period can significantly
modulate the gene expression related to inflammation in the OB
via the proper activation of xenobiotic metabolism, eventually
resulting in neuroprotection (25). Consistent with the previous
study, our results showed the beneficial effects of EE that
can alleviate endogenous oxidative stress via the glutathione-
mediated ROS detoxification in the adult mouse brain and
can also mediate neuroprotection, resulting in more newly
regenerated cells in the RMS and modulation of the OB circuits.
Previous studies suggested that the complexity of the
environment is the key feature of EE that can provide a wide
range of opportunities for stimulation in various brain regions
(21, 58–60). In our study, we provided larger space with the
items varying in size, shape, smell, and texture in EE. The
active interaction between the mice and items available in
the environment may lead to dramatic results in endogenous
ROS detoxification of normal adult mice. However, since the
activity response of antioxidant enzymes in the brain is probably
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dependent on various factors such as the duration of EE, sex, and
strain of mice, further prospective studies to evaluate the effect of
EE based on these factors are needed.
Since there is little information available for the effect of EE on
the intact OB of normal mice, our study may provide a possible
protective mechanism of EE. In the present study, the proteomic
analysis revealed the DEPs, which are associated with metabolic
pathways and xenobiotic metabolism, in EE mice compared with
control mice. EE can induce the neuroprotective effects via the
up-regulation of glutathione-associated antioxidant enzymes in
the OB. EE also creates the optimal state against ROS by the
up-regulation of GSH/GSSG ratio, down-regulation of iNOS
expression and apoptotic process, and up-regulation of cell
proliferation.
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